Updated Jul 16, 2026
Warren Eric has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.70M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | MLYS | Mineralys Therapeutics, Inc. | S — Open-market sale | 104.1K | $25.90 | $2.70M |
| 2026-06-30 | MLYS | Mineralys Therapeutics, Inc. | M — Option exercise | 104.1K | $13.24 | $1.38M |
| 2024-12-18 | ESPR | Esperion Therapeutics, Inc. | S — Open-market sale | 2.2K | $2.43 | $5K |
| 2024-11-20 | ESPR | Esperion Therapeutics, Inc. | S — Open-market sale | 197 | $2.17 | $427 |
| 2024-10-18 | ESPR | Esperion Therapeutics, Inc. | S — Open-market sale | 107 | $2.12 | $227 |
Warren Eric is a corporate insider — currently tracked as Chief Commercial Officer of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($2.70M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Warren Eric profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.